IAM
MRK icon

Innovis Asset Management’s Merck MRK Stock Holding History

Innovis Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$7.54M Buy
73,264
+31
+0% +$3.34K 2.91% 7
2023
Q2 		$8.45M Buy
73,233
+17,377
+31% +$1.97M 3.12% 4
2023
Q1 		$5.94M Buy
55,856
+5,114
+10% +$552K 2.41% 14
2022
Q4 		$5.63M Buy
+50,742
New +$5.19M 2.54% 14

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Innovis Asset Management's MRK Position: Q3 2023 in Review

Innovis Asset Management increased its Merck (MRK) stake by 0.04% in Q3 2023, buying an estimated $3.34K and bringing the position to 73,264 shares worth $7.54M. The position accounts for 2.91% of the portfolio, ranked #7.

Innovis Asset Management first reported a position in MRK in Q4 2022 and has held it in 4 quarters since. The position peaked at $8.45M in Q2 2023. 3,215 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Innovis Asset Management held 73,264 shares of Merck worth $7.54M as of Q3 2023.
  • Innovis Asset Management bought 31 Merck shares in Q3 2023, an estimated $3.34K.
  • Merck made up 2.91% of Innovis Asset Management's portfolio in Q3 2023, its #7 holding.
  • Innovis Asset Management first reported a position in Merck in Q4 2022 and has held it in 4 quarters since.
  • Innovis Asset Management's Merck position peaked at $8.45M in Q2 2023.
  • 3,215 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.